SUMMARY Plasma fibronectin concentration was measured in neonates of 2 to 5 days of age. Although breast fed and formula fed infants were similar in demographic characteristics, the mean (SD) plasma concentration of fibronectin in 26 breast fed infants, 237 (117) mg/I, was significantly higher than in 27 formula fed infants (171 (91) mg/l). Fibronectin was detected in five colostrum specimens (mean concentration 13*4 mg/l). Similar bands were detected after gel electrophoresis of purified adult plasma fibronectin and whole plasma from breast fed and formula fed neonates after staining or immunoblotting. Fibronectin isolated from breast mill also appeared similar to purified plasma fibronectin. It is possible, although unlikely, that fibronectin is absorbed intact from ingested colostrum. Alternatively, a factor(s) might be present in colostrum that contributes to the regulation of plasma fibronectin concentration.
Fibronectin is a high molecular weight glycoprotein found in plasma and on cell surfaces. Plasma fibronectin acts as a non-specific opsonin, augmenting macrophage and neutrophil phagocytosis, and modulating reticuloendothelial clearance of bacteria and intravascular debris. Therefore it has a potentially important role in host defence against infection. The major sources of plasma fibronectin include hepatocytes, macrophages, and endothelial cells.' The concentration of plasma fibronectin is lower in newborn infants compared with children and adults and further decreased in neonates with sepsis.2
Human milk has been shown to contain fibronectin that is immunologically cross reactive with plasma fibronectin.3 We have compared plasma fibronectin concentrations in healthy, term, breast fed and formula fed neonates. In addition, fibronectin concentrations were measured in colostrum and several commercial infants formulas.
Methods

STUDY POPULATION
The study group consisted of healthy term infants who were receiving no medication. Blood for assay was collected two to five days after birth at the time of sampling for state metabolic screening. The (fig 1) . The mean (SD) plasma fibronectin concentration in 23 healthy adult volunteers was 576-0 (252) mg/l within the range of previously reported values.7
The mean (SD) fibronectin concentration in five colostrum specimens was 13-4 (4-7) mg/l (range 6-9-19-5). Fibronectin was not detected in whole cows' milk or four commercial infant formulas. The limit of detection for the assay was 0-05 mg/l.
Coomassie blue staining after SDS-PAGE showed a doublet in the lanes containing purified adult plasma fibronectin and pooled plasma samples from breast or formula fed neonates which corresponded to a molecular weight of roughly 220 kilodaltons ( fig 2, lanes 1-3) . Electrophoretic transfer and immunoblotting with antifibronectin antibody showed similar bands in lanes containing purified fibronectin, or plasma from breast or formula fed infants (fig 2, lanes 4 and 5) . Even with deliberate overloading of lanes with plasma, there were no lower molecular weight immunoreactive fibronectin fragments detected in the plasma of breast or formula fed neonates. Fibronectin isolated from human breast milk also appeared similar to purified human plasma fibronectin (fig 2, lane 6 ).
Discussion
Our results support previous studies that have observed lower plasma fibronectin concentrations in neonates in comparison with older infants and adults.7 In this investigation we have shown that breast fed neonates have higher plasma fibronectin concentrations than those who were formula fed. The two groups of infants were comparable in demographic and clinical variables. The greater depletion of intravascular volume in the nursing neonates, as evidenced by a greater percentage of weight loss from birth, could be invoked to explain differences in the concentration of l plasma protein; however, even if the entire difference was due to intravascular water, this apparent 2% difference in weight loss could not explain the 39%O increase in the plasma fibronectin concentration observed. Inadequate nutrition results in a lowering of plasma fibronectin concentrations.8 9 Therefore the lower caloric intake of breast fed neonates in the first days of life compared with those formula fed would be predicted to result in a lower concentration of fibronectin in the plasma of the breast fed neonates, not the raised concentrations observed.
Although there was no significant difference in postnatal age between the two groups, the breast fed infants were somewhat older than the formula fed infants. We considered the possibility that the differences in fibronectin concentrations found may in part be influenced by this small difference in age. A significant correlation was found (r=0-477, p<001) between postnatal age and plasma fibronectin concentrations for the entire group of infants. Thus it is possible that the slightly older postnatal age of the nursing infants influenced our findings.'0
When the two groups were analysed independently, however, the correlation reached significance in the breast fed infants (r=0-53, p<001) but not the formula fed infants (r=0.27, p>0 10). If fibronectin concentrations were influenced solely by age, we would expect to observe a positive correlation between postnatal age and plasma fibronectin concentration in the formula fed group. Because fibronectin may have an important role in opsonisation and clearance of bacteria, decreased concentrations may be a factor contributing to the neonate's increased susceptibility to and mortality from bacterial infection. Though the difference in plasma concentrations observed in breast fed and formula fed neonates is significant, it is unclear whether the 39% higher mean concentration in the breast fed infants is important clinically. As the plasma fibronectin concentrations of adults are more than twice that of neonates, it is clear that there are other factors that have a major role in the regulation of plasma fibronectin concentration. It is not known whether this difference in fibronectin concentration is carried beyond the first few days of life.
We hypothesise several possible mechanisms to account for the differences observed. We have confirmed a previous report that documented the presence of fibronectin in colostrum3; therefore, direct absorption of fibronectin may be possible. The significant correlation between postnatal age anyd fibronectin concentrations in the breast fed infants lends support to this hypothesis. As infants who were older would have ingested a larger amount of colostrum, the older breast fed infant might be expected to have higher fibronectin concentrations than his younger counterpart if direct absorption occurred. The similar electrophoretic mobility and immunoreactivity of fibronectin isolated from breast milk and adult plasma precludes the detection of breast milk fibronectin in the plasma of breast fed infants using this method. It is not clear, however, whether a large, protease susceptible protein such as fibronectin could be absorbed intact. Studies have shown that the capacity to absorb macromolecules may be more extensive in the immature small intestine than in the highly developed mature intestine." In addition, it has been suggested that in the newborn period, a greater quantity of protein ingested by intestinal epithelial cells escapes intracellular proteolysis as a result of immature lysozymal function, and therefore more protein becomes available for subsequent transport out of the cell and into the circulation."
As we assayed immunoreactive fibronectin it is possible that we have measured both intact fibronectin and degraded fragments in plasma. The immunoblot analysis of plasma fibronectin from breast fed infants, however, showed no evidence of fibronectin fragments. Furthermore, the difference in plasma fibronectin concentration in breast fed and formula fed infants is not easily accounted for on the basis of fibronectin in breast milk. A newborn ingests more than 500 ml of colostrum in the first three days of life.'2 Given a fibronectin concentration in colostrum of 13 mg/l, the infant would ingest 6 5 mg of fibronectin. Assuming a plasma volume of 150 ml, even complete absorption of ingested fibronectin from the gastrointestinal tract, without intravascular clearance, could account for only two thirds of the increase in plasma fibronectin concentrations observed in the breast fed infants.
A second hypothesis to explain the difference found is that there may be a factor(s) in breast milk that promotes an increase in fibronectin synthesis. This increased production may be specific for fibronectin or may be part of a generalised increase in protein synthesis by hepatocytes, endothelial cells, or other fibronectin producing cells.
Alternatively, there may be factors unrelated to absorption of fibronectin from the gastrointestinal tract or to fib-ronectin production. For example, the plasma half life of fibronectin may be prolonged in breast fed infants.
Human milk has been shown to contain several immunologically active elements. Cellular components include macrophages, lymphocytes, and neutrophils; humoral elements include immunoglobulins, lysozyme, and lactoferrin. '3 Several studies have shown that breast fed infants have lower infection rates than formula fed infants. 14 A significant association has been found between breast feeding and decreased rates of gastrointestinal illness. There is less conclusive evidence that breast feeding may protect against respiratory illness and otitis media.'3 In addition, there appears to be a protective influence of breast feeding on the risk of developing invasive Haemophilus influenzae type b disease. '5 It is possible that the raised plasma fibronectin concentrations in nursing infants may represent a means by which breast feeding may contribute to their lower risk of infection. Further studies are needed to determine the mechanism that causes the raised plasma fibronectin concentrations in breast fed infants, compared with those who are formula fed, and to determine if this raised concentration persists in later infancy; there is also a need to assess the potential contribution of this quantitative difference in protection of the newborn against infection.
